Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 10,906 | 9,389 | 7,406 | 0 | 0 |
| Cost of Goods | 1,673 | 1,672 | 2,316 | N/A | N/A |
| Gross Profit | 9,233 | 7,717 | 5,090 | N/A | N/A |
| Operating Expenses | 22,994 | 20,393 | 20,768 | 3,230 | 1,834 |
| Operating Income | -13,088 | -12,004 | -15,362 | -3,230 | -1,834 |
| Interest Expense | 2,353 | 1,314 | 1,346 | 219 | 134 |
| Other Income | 5,203 | -15,269 | 5 | 0 | 0 |
| Pre-tax Income | -10,238 | -28,586 | -16,703 | -3,449 | -1,968 |
| Income Tax | N/A | -6,922 | -465 | N/A | N/A |
| Net Income Continuous | -10,238 | -21,664 | -16,238 | -3,449 | -1,968 |
| Net Income | $-10,238 | $-21,664 | $-16,238 | $-3,449 | $-1,968 |
| EPS Basic Total Ops | -3.09 | -9.15 | -5.30 | -5.38 | -3.21 |
| EPS Basic Continuous Ops | -3.09 | -9.14 | -5.30 | -5.38 | -3.21 |
| EPS Diluted Total Ops | -3.09 | -9.15 | -5.30 | -5.38 | -3.21 |
| EPS Diluted Continuous Ops | -3.09 | -9.14 | -5.30 | -5.38 | -3.21 |
| EPS Diluted Before Non-Recurring Items | -3.09 | -2.83 | -5.30 | -5.38 | -3.20 |
| EBITDA(a) | $-11,323 | $-10,787 | $-14,220 | $-3,066 | $-1,740 |